In a setback for GlaxoSmithKline, the same federal judge who recently remanded eight Paxil birth defect suits to state court has now been assigned by his chief judge to decide the fate of another 21 cases despite GSK’s protests of "judge shopping."

"We disagree with defendant that it is unfair to transfer the motions to Judge [Timothy] Savage, who is extremely familiar with the issue involved and has already ruled on the motions in other Paxil cases," Chief Judge Harvey Bartle III wrote.